Credit: Getty Images. A review of recent medical-related criminal activity related to the unlawful dispensing and distribution of prescription medications. Oncology Practice Pays Over $1 Million to ...
The closed-loop feature of the Inceptiv SCS senses neural responses and is able to automatically adjust stimulation in real time. The Food and Drug Administration (FDA) has approved the Inceptiv ™ ...
Results showed a reduction in annualized bleeding rate after a single infusion of fidanacogene elaparvovec compared with standard of care. The Food and Drug Administration (FDA) has approved Beqvez ™ ...
No new safety or tolerability concerns were observed with Biktarvy during pregnancy and postpartum. The Food and Drug Administration (FDA) has approved updated labeling for Biktarvy ® (bictegravir ...
The Food and Drug Administration (FDA) has approved Pivya (pivmecillinam) for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (UTIs) caused by ...
CTX-009 is a bispecific antibody that simultaneously blocks Delta-like ligand 4 and vascular endothelial growth factor A. The Food and Drug Administration (FDA) has granted Fast Track designation to ...
The nasal spray product delivers 10mg of naloxone hydrochloride in a single dose. The Food and Drug Administration (FDA) has approved Rezenopy (naloxone hydrochloride) nasal spray for the emergency ...
MamaLift Plus is the first prescription digital therapeutic to get FDA clearance for postpartum depression treatment. The Food and Drug Administration (FDA) has cleared MamaLift Plus, the first ...
Dr. Reddy’s Laboratories Ltd is voluntarily recalling 6 lots of Sapropterin Dihydrochloride Powder for Oral Solution 100mg due to powder discoloration in some packets leading to decreased potency.
The deficiencies noted in the CRL were not related to efficacy or safety data. The Food and Drug Administration (FDA) has issued a Complete Response Letter to Abeona Therapeutics regarding the ...
The CDC Advisory Committee on Immunization Practices February meeting covered vaccinations for COVID-19, influenza, RSV, and pneumococcal infections.
Ojemda is the first FDA-approved systemic therapy for pediatric LGG patients with BRAF rearrangements, including fusions. The Food and Drug Administration (FDA) has granted accelerated approval to ...